83 related articles for article (PubMed ID: 3814302)
1. Grading ovarian tumors. Evaluation of decision making by different pathologists.
Baak JP; Delemarre JF; Langley FA; Talerman A
Anal Quant Cytol Histol; 1986 Dec; 8(4):349-53. PubMed ID: 3814302
[TBL] [Abstract][Full Text] [Related]
2. Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing.
Baak JP; Langley FA; Talerman A; Delemarre JF
Anal Quant Cytol Histol; 1986 Dec; 8(4):354-7. PubMed ID: 3814303
[TBL] [Abstract][Full Text] [Related]
3. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
[TBL] [Abstract][Full Text] [Related]
4. The prognostic variability of ovarian tumor grading by different pathologists.
Baak JP; Langley FA; Talerman A; Delemarre JF
Gynecol Oncol; 1987 Jun; 27(2):166-72. PubMed ID: 3570055
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
[TBL] [Abstract][Full Text] [Related]
6. Observer disagreement in histological classification of ovarian tumors in Japan.
Sakamoto A; Sasaki H; Furusato M; Suzuki M; Hirai Y; Tsugane S; Fukushima M; Terashima Y
Gynecol Oncol; 1994 Jul; 54(1):54-8. PubMed ID: 8020839
[TBL] [Abstract][Full Text] [Related]
7. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
Malpica A; Deavers MT; Tornos C; Kurman RJ; Soslow R; Seidman JD; Munsell MF; Gaertner E; Frishberg D; Silva EG
Am J Surg Pathol; 2007 Aug; 31(8):1168-74. PubMed ID: 17667538
[TBL] [Abstract][Full Text] [Related]
8. Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group.
Yamamoto S; Kasajima A; Takano M; Yaegashi N; Fujiwara H; Kuzuya K; Kigawa J; Tsuda H; Kurachi H; Kikuchi Y; Sugiyama T; Tsuda H; Moriya T
Int J Gynecol Pathol; 2011 Mar; 30(2):129-38. PubMed ID: 21293288
[TBL] [Abstract][Full Text] [Related]
9. [Ovarian epithelial tumors of borderline malignancy].
Katoh K; Izumi R
Rinsho Byori; 1992 Feb; 40(2):119-31. PubMed ID: 1583784
[TBL] [Abstract][Full Text] [Related]
10. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.
Sorbe B; Frankendal B; Veress B
Obstet Gynecol; 1982 May; 59(5):576-82. PubMed ID: 7070728
[TBL] [Abstract][Full Text] [Related]
11. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system.
Shimizu Y; Kamoi S; Amada S; Hasumi K; Akiyama F; Silverberg SG
Gynecol Oncol; 1998 Jul; 70(1):2-12. PubMed ID: 9698465
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.
Scholten AN; Smit VT; Beerman H; van Putten WL; Creutzberg CL
Cancer; 2004 Feb; 100(4):764-72. PubMed ID: 14770433
[TBL] [Abstract][Full Text] [Related]
13. Interobserver variability in the interpretation of epithelial ovarian cancer.
Hernandez E; Bhagavan BS; Parmley TH; Rosenshein NB
Gynecol Oncol; 1984 Jan; 17(1):117-23. PubMed ID: 6693048
[TBL] [Abstract][Full Text] [Related]
14. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implications.
Lund B; Thomsen HK; Olsen J
APMIS; 1991 Apr; 99(4):353-8. PubMed ID: 2036219
[TBL] [Abstract][Full Text] [Related]
16. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum.
Seidman JD; Horkayne-Szakaly I; Cosin JA; Ryu HS; Haiba M; Boice CR; Yemelyanova AV
Gynecol Oncol; 2006 Nov; 103(2):703-8. PubMed ID: 16828848
[TBL] [Abstract][Full Text] [Related]
17. Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies.
Barnard ME; Pyden A; Rice MS; Linares M; Tworoger SS; Howitt BE; Meserve EE; Hecht JL
Gynecol Oncol; 2018 Sep; 150(3):521-526. PubMed ID: 30001835
[TBL] [Abstract][Full Text] [Related]
18. Pathology of epithelial ovarian cancer.
Tornos C; Silva EG
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):63-77. PubMed ID: 8015767
[TBL] [Abstract][Full Text] [Related]
19. Minimum spanning tree analysis in advanced ovarian carcinoma. An investigation of sampling methods, reproducibility and correlation with histologic grade.
Brinkhuis M; Meijer GA; van Diest PJ; Schuurmans LT; Baak JP
Anal Quant Cytol Histol; 1997 Jun; 19(3):194-201. PubMed ID: 9196801
[TBL] [Abstract][Full Text] [Related]
20. Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer.
Barber HR; Sommers SC; Synder R; Kwon TH
Am J Obstet Gynecol; 1975 Mar; 121(6):795-807. PubMed ID: 1092171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
